After treatment, in terms of liver function, the levels of aspartate aminotransferase, alanine aminotransferase (ALT), and cholinesterase (CHE), as well as prothrombin time and AFP level as indicators of coagulation function and tumor marker, respectively, in the two groups of patients were better compared with those before treatment (p < 0.05, Table 4). The gene discussed is GPT; the disease is neoplasm.